Cyclerion

Performance

About Cyclerion

Cyclerion Therapeutics is a biopharmaceutical company focused on developing personalized therapies for treatment-resistant depression (TRD). The company combines validated therapeutic approaches with a tech-enabled, biofeedback-driven delivery system to tailor treatments to individual patients, aiming to improve safety and efficacy in neuropsychiatric care. Based in the United States, Cyclerion emphasizes precision medicine and CNS-focused research to transform mental health treatment for TRD and related conditions.